You are here

Home

Global Health

Primary tabs

Mon, 2009-03-09 11:54 — mdmcdonald

The mission of the Global Health Working Group is to explore and improve current and emerging states of health and human security worldwide.

General Topic Tags: 
Adaptation
Problem, Solution, SitRep, or ?: 
Solutions
Group: 
Request group membership
Group description: 
This Working Group is focused on exploring current and emerging states of health and human security worldwide.
Group roles and permissions: 
Use default roles and permissions
Group visibility: 
Public - accessible to all site users

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Aboubacar Conte admin Albert Gomez Allan Anthony Carrielaj
Chisina Kapungu ChrisAllen Corey Watts CPetry DeannaPolk Elhadj Drame
Gavin Macgregor... Hadiatou Balde hank_test jranck JSole Kathy Gilbeaux
Lisa Stelly Thomas loguest Maeryn Obley mdmcdonald MDMcDonald_me_com Mika Shimizu
mike kraft njchapman Norea Tiaji Salaam-Blyther tnovotny
Request group membership

Email address for group

COVID-19 may contribute to Cholesterol Problems --research

Tue, 2023-05-30 17:56 — mike kraft

...Medical researchers have also linked SARS-CoV-2 to lingering complications in multiple organs and systems, and some recent work has found that new-onset cholesterol problems may be an under-recognized but common complication of COVID-19.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Solutions
Situation Report

Bivalent COVID vaccine efficacy at 6 months drops 24% against hospitalization, strong against death --CDC study

Tue, 2023-05-30 17:48 — mike kraft
Bivalent COVID vaccine efficacy at 6 months: 24% against hospitalization, strong against death CIDRAP

Estimated bivalent (two-strain) COVID-19 mRNA vaccine effectiveness (VE) against hospitalization dropped from 62% 1 week after receipt to 24% at 4 to 6 months in adults with healthy immune systems, but protection against severe outcomes was sustained, according to a US Centers for Disease Control and Prevention (CDC) study.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Data
Disease
Disease Prevention
Government
Health
Mutations
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Healthy Sleep Patterns Might Reduce Long Covid Risk--study

Tue, 2023-05-30 12:56 — mike kraft
Healthy Sleep Patterns Might Reduce Long Covid Risk In a new JAMA study, researchers found that people who had health sleep patterns prior to a Covid infection — both before and after the Covid-19 pandemic began — may h... Anuradha Varanasi Forbes
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Risk of new post-COVID mental disorders higher only in older patients-- study

Fri, 2023-05-26 20:17 — mike kraft
Risk of new post-COVID mental disorders higher only in older patients, study suggests Data suggest an increased risk of new-onset mental illness only in SARS-CoV-2–positive patients aged 70 and older. CIDRAP
Country / Region Tags: 
Europe
Global
General Topic Tags: 
COVID-19
Symptoms
Data
Demographics
Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Pfizer COVID tracking confirms safety for kids, heart issues extremely rare.

Fri, 2023-05-26 11:36 — mike kraft
Pfizer COVID vaccine tracking confirms safety in kids, with myocarditis, pericarditis rare CIDRAP

Monitoring of Pfizer/BioNTech COVID-19 vaccine safety among more than 3 million US children aged 5 to 17 years flagged just 2 of 20 health outcomes among 12- to 17-year-olds—myocarditis and pericarditis, which were rare.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Demographics
Disease Prevention
Health
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Prepare for future pathogens with "even deadlier potential" than COVID, WHO chief warns

Thu, 2023-05-25 17:45 — mike kraft
Prepare for next pandemic, future pathogens with "even deadlier potential" than COVID, WHO chief warns WHO director-general Dr. Tedros Adhanom Ghebreyesus is urging the world to be ready for the next pandemic, saying future outbreaks could be even worse than COVID. CBS News

...

Country / Region Tags: 
Global
United Nations
General Topic Tags: 
COVID-19
Disease Prevention
Government
Mutations
Pandemics
Policy
Public Attitudes
Problem, Solution, SitRep, or ?: 
Analysis

China faces a new Covid wave that could peak at 65 million cases a week

Thu, 2023-05-25 17:34 — mike kraft
China faces a new Covid wave that could peak at 65 million cases a week China is bracing for a new wave of Covid-19 infections that could see as many as 65 million cases per week by the time the surge peaks at the end of June. Yahoo News

...

Country / Region Tags: 
Asia
China
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Public Health
Social behavior
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

12 key symptoms define long Covid, new study shows, bringing treatments closer

Thu, 2023-05-25 16:47 — mike kraft
Government-funded study creates first symptom-based long Covid definition, a step toward finding treatments | CNN After more than two years and an investment of nearly $1.2 billion, researchers say they’ve come up with a list of 12 symptoms that can reliably classify someone as having long Covid, a working definition that should accelerate research into the disabling condition. CNN
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Government
Health
Pandemics
Public Attitudes
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

Thu, 2023-05-25 16:42 — mike kraft
COVID pill Paxlovid gets full FDA approval after more than a year of emergency use U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid. Thursday's action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely. Millions of Americans have received Paxlovid since it was granted emergency authorization in late 2021. It’s become the go-to treatment for adults and older children. The FDA’s approval is only for adults who are at high risk of hospitalization or death from COVID-19. The drug is still available for children under emergency use. AP NEWS
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Government
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Air pollution exposure linked to severe COVID-19 outcomes--study

Thu, 2023-05-25 16:36 — mike kraft
Air pollution exposure linked to severe COVID-19 outcomes CIDRAP

Air pollution exposure is associated with a higher risk of experiencing severe outcomes from COVID-19 infections, including intensive care unit (ICU) admissions and death, according to new evidence in Nature Communications from the Barcelona Institute for Global Health (ISGlobal).

...

Country / Region Tags: 
Europe
Global
Spain
General Topic Tags: 
COVID-19
Symptoms
Disease
Public Health
Pollution
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Pages

howdy folks
Page loaded in 0.959 seconds.